464P - Pharmacokinetic (PK) assessment of BT1718: A phase I/II a study of BT1718, a first in class bicycle toxin conjugate (BTC), in patients (pts) with advanced solid tumours
| Autor: | Cook, N., Banerji, U., Evans, J., Biondo, A., Germetaki, T., Randhawa, M., Godfrey, L., Leslie, S., Jeffrey, P., Rigby, M., Bennett, G., Blakemore, S., Koehler, M., Niewiarowski, A., Pittman, M., Symeonides, S.N. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v174-v174 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|